These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1828382)

  • 1. Medical or surgical orchidectomy.
    Parmar H; Edwards LE; Phillips RH; Charlton C; Lightman SI
    BMJ; 1991 May; 302(6787):1272. PubMed ID: 1828382
    [No Abstract]   [Full Text] [Related]  

  • 2. LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade.
    Jacobi GH
    Recent Results Cancer Res; 1990; 118():174-85. PubMed ID: 2146724
    [No Abstract]   [Full Text] [Related]  

  • 3. How would you like to have an orchidectomy for advanced prostatic cancer?
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Am J Clin Oncol; 1988; 11 Suppl 2():S160-8. PubMed ID: 2977271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orchidectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer.
    Williams G
    Lancet; 1986 Jan; 1(8473):157. PubMed ID: 2867375
    [No Abstract]   [Full Text] [Related]  

  • 5. Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
    De Sy WA; De Wilde P; De Meyer JM; Casselman J; Desmet R; Renders G; Schelfhout W
    Acta Urol Belg; 1988; 56(4):581-8. PubMed ID: 2974680
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 9. Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
    Botto H; Richard F; Mathieu F; Camey M
    Prog Clin Biol Res; 1989; 303():53-60. PubMed ID: 2528740
    [No Abstract]   [Full Text] [Related]  

  • 10. LHRH analogues in prostatic cancer.
    Lancet; 1986 Feb; 1(8478):445-6. PubMed ID: 2868364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of LHRH agonists in the treatment of advanced cancer of the prostate].
    Fretin J
    Arch Esp Urol; 1990; 43(6):647-9. PubMed ID: 2151155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].
    Marcellino LR; Campanella A; Bandini M
    Biomed Pharmacother; 1987; 41(9-10):468-72. PubMed ID: 2968123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone analogs and prostatic cancer.
    Swanson LJ; Seely JH; Garnick MB
    Crit Rev Oncol Hematol; 1988; 8(1):1-26. PubMed ID: 2964939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial.
    Østergren PB; Kistorp C; Fode M; Henderson J; Bennedbæk FN; Faber J; Sønksen J
    J Urol; 2017 Jun; 197(6):1441-1447. PubMed ID: 27939836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.
    Deghenghi R; Misset JL
    Lancet; 1984 Jun; 1(8389):1302. PubMed ID: 6145013
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
    De Sy WA; de Meyer JM; Casselman J; De Smet R; Renders G; Schelfhout W; De Wilde P
    Acta Urol Belg; 1986; 54(2):221-9. PubMed ID: 2942015
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer].
    Labrie F; Dupont A; Bélanger A; Lacourcière Y; Monfette JE; Monfette G
    Ann Urol (Paris); 1986; 20(2):98-106. PubMed ID: 2940959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dramatic aggravation of prostatic cancer at the onset of treatment with an LHRH agonist].
    Boumier P; Koeger AC; Camus JP
    Presse Med; 1985 May; 14(21):1200-1. PubMed ID: 3158996
    [No Abstract]   [Full Text] [Related]  

  • 19. Triptorelin in the management of prostate cancer.
    Ploussard G; Mongiat-Artus P
    Future Oncol; 2013 Jan; 9(1):93-102. PubMed ID: 23252566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and maintenance of castration by an LHRH analogue: D-Trp6 LHRH or decapeptyl.
    Fretin J; Demerle F; Jardin A
    Prog Clin Biol Res; 1987; 243A():245-7. PubMed ID: 2958855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.